Arvinas

For over 25 years, Will Kattell has been connecting great talent with impactful roles. At Arvinas, he ensures a seamless hiring process across functions, evaluating candidates and supporting hiring managers. Will’s favorite part of recruiting? Watching candidates grow into successful colleagues who help advance our mission of improving patients’ lives. Outside of work, Will’s routine includes 4:30 a.m. gym sessions, morning coffee, and catching every episode of Survivor (yes, all 47 seasons!). He dreams of one day visiting Antarctica to visit the penguins and explore the South Pole. Learn more about other members of #TeamArvinas here: https://rb.gy/lhp36x   #TeamArvinas #MeetTeamArvinas #WorkAtArvinas #EmployeeExperience #CompanyCulture

At Arvinas, we honor the life and legacy of Dr. Martin Luther King Jr., a leader who showed us the power of purpose, courage, and action. Dr. King's vision for equality and justice inspires us every day to build a more inclusive world—within our company, our industry, and the communities we serve. Today, as we reflect on his words and the impact of his leadership, we recommit to fostering a culture of respect, diversity, and belonging where every voice matters. #MLKDay #TeamArvinas

Check out #Arvinas Chairperson, Chief Executive Officer, and President John Houston’s interview with Biotech TV! This feature explores our innovative journey in targeted #proteindegradation. Check out the video to learn more about the science driving our mission. #TeamArvinas #Innovation #ProteinDegradation #TPD

#Arvinas is working to unlock the potential of #PROTAC protein degraders to directly eliminate disease-causing proteins from cells. Hear from our Chief Scientific Officer, Angela Cacace, Ph.D., as she shares how we are leveraging our PROTAC technology to further our clinical development strategies. Learn More: https://bit.ly/403zZ6Q #ScienceOfPROTAC #ClinicalResearch #ThoughtLeadership #Science

#NEWS: Arvinas updates guidance for first- and second-line phase 3 combination trials with its investigational #PROTAC ER degrader in patients with ER+/HER2- advanced or metastatic #breastcancer, highlights upcoming milestones, and provides a corporate update. Read our full press release here: bit.ly/4gNEgTj

It is an honor to be a presenting company at Biohaven and Yale University's pre #JPM25 conference event along other esteemed life sciences companies in New Haven. #InnovationInScience #TeamArvinas

As we step into a new year, one thing remains steadfast: our mission to change lives through groundbreaking science. At Arvinas, our journey began with a visionary idea from our founder, Dr. Craig Crews, who saw the potential to push the boundaries of what’s possible in biotech. His pioneering work in targeted protein degradation laid the foundation for who we are today—a company dedicated to transforming the lives of patients through innovation. Curious about how it all started? Discover our founding story and the passion that drives us forward, straight from Dr. Crews himself: https://bit.ly/3WbKuEh Here’s to another year of innovation, impact, and staying true to our mission.     #Oncology #CancerResearch #Neuroscience #Biotech #TeamArvinas

As we wrap up an inspiring year of progress and collaboration, we’d like to take a moment to thank #TeamArvinas, our partners and the #NHV community for their support. Wishing everyone a joyful and peaceful holiday season and a bright start to the new year! #HappyHolidays

In his latest blog, our Chief Medical Officer, Noah Berkowitz, M.D., Ph.D., shares his deeply personal journey and how it has shaped his lifelong dedication to advancing cancer treatment. From witnessing the loss of loved ones to the inspiration he draws from the boundless potential of science, Dr. Berkowitz reflects on the progress made in breast cancer treatments and the promise of innovative approaches like PROTAC protein degraders in transforming patient care. Join us in exploring his perspective and the work being done at #Arvinas aiming to help improve outcomes for people living with cancer. #TeamArvinas #Leadership #ArvinasInsights #Innovation #CancerResearch

Representation matters, and progress is happening! Researchers report that kids today are more likely than ever to imagine scientists as women—proof that breaking barriers inspires the next generation of innovators. At Arvinas, we’re proud to celebrate the incredible contributions of #WomenInSTEM who continue to lead, discover, and innovate. But we know there’s more work to be done. By fostering inclusivity, breaking down barriers, and paving the way for new opportunities, we’re committed to building a future where everyone sees themselves in science. Let’s inspire change together! See the data here: https://bit.ly/4fSZ5fB   #TeamArvinas #FutureInnovators #BreakingBarriers